Skip to main content
. 2020 Jul 16;11(9):2389–2397. doi: 10.1111/1759-7714.13521

Figure 1.

Figure 1

Establishment of osimertinib‐resistant H1975OR cells. (a) The IC50 of osimertinib in H1975S and H1975OR (Inline graphic) H1975s, and (Inline graphic) H1975OR; (b) The IC50 of palbociclib in H1975S and H1975OR (Inline graphic) H1975S, and (Inline graphic) H975OR; (c, d). CCK8 and colony formation of H1975S (Inline graphic) 1975, and (Inline graphic) H1975 and H1975OR; (e) Cell cycle of H1975S (Inline graphic) Dip G1, (Inline graphic) Dip G2, and (Inline graphic) Dip S; (f) Cell cycle of H1975OR (Inline graphic) Dip G1, (Inline graphic) Dip G2, and (Inline graphic) Dip S.